Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TRANS-ACTIVATOR GENE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 114 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jonas, G; Hoffmann, S; Willbold, D
      Binding of phage-displayed HIV-1 Tat to TAR RNA in the presence of cyclin T1

      JOURNAL OF BIOMEDICAL SCIENCE
    2. Cafaro, A; Titti, F; Fracasso, C; Maggiorella, MT; Baroncelli, S; Caputo, A; Goletti, D; Borsetti, A; Pace, M; Fanales-Belasio, E; Ridolfi, B; Negri, DRM; Sernicola, L; Belli, R; Corrias, F; Macchia, I; Leone, P; Michelini, Z; ten Haaft, P; Butto, S; Verani, P; Ensoli, B
      Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)

      VACCINE
    3. Ha, HC; Juluri, K; Zhou, Y; Leung, S; Hermankova, M; Snyder, SH
      Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    4. Sei, S; O'Neill, DP; Stewart, SK; Yang, QE; Kumagai, M; Boler, AM; Adde, MA; Zwerski, SL; Wood, LV; Venzon, DJ; Magrath, IT
      Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma

      CANCER RESEARCH
    5. Li, XG; Josef, J; Marasco, WA
      HIV-1 Tat can substantially enhance the capacity of NIK to induce I kappa B degradation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    6. Ensoli, B; Cafaro, A
      Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 TAT vaccine

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    7. Kar-Roy, A; Dong, W; Michael, N; Li, Y
      Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1

      JOURNAL OF VIROLOGICAL METHODS
    8. Cafaro, A; Caputo, A; Maggiorella, MT; Baroncelli, S; Fracasso, C; Pace, M; Borsetti, A; Sernicola, L; Negri, DRM; Ten Haaft, P; Betti, M; Michelini, Z; Macchia, I; Fanales-Belasio, E; Belli, R; Corrias, F; Butto, S; Verani, P; Titti, F; Ensoli, B
      SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine

      JOURNAL OF MEDICAL PRIMATOLOGY
    9. Ensoli, B; Butto, S
      The development of a vaccine against AIDS based on the HIV-1 Tat protein

      SOUTH AFRICAN JOURNAL OF SCIENCE
    10. Hamaguchi, I; Woods, NB; Panagopoulos, I; Andersson, E; Mikkola, H; Fahlman, C; Zufferey, R; Carlsson, L; Trono, D; Karlsson, S
      Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro

      JOURNAL OF VIROLOGY
    11. Philippon, Y; Matsuda, Z; Essex, M
      Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx

      JOURNAL OF HUMAN VIROLOGY
    12. Cafaro, A; Caputo, A; Fracasso, C; Maggiorella, MT; Goletti, D; Baroncelli, S; Pace, M; Sernicola, L; Koanga-Mogtomo, ML; Betti, M; Borsetti, A; Belli, R; Akerblom, L; Corrias, F; Butto, S; Heeney, J; Verani, P; Titti, F; Ensoli, B
      Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat proteinvaccine

      NATURE MEDICINE
    13. Daelemans, D; Vandamme, AM; De Clercq, E
      Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    14. Taube, R; Fujinaga, K; Wimmer, J; Barboric, M; Peterlin, BM
      Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation

      VIROLOGY
    15. Favaro, JP; Maldarelli, F; Arrigo, SJ; Schmidt, MG
      Effect of Rev on the cytoplasmic localization of intron-containing human immunodeficiency virus type 1 RNA

      VIROLOGY
    16. Wimmer, J; Fujinaga, K; Taube, R; Cujec, TP; Zhu, YR; Peng, JM; Price, DH; Peterlin, BM
      Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b

      VIROLOGY
    17. Fujinaga, K; Taube, R; Wimmer, J; Cujec, TP; Peterlin, BM
      Interactions between human cyclin T, Tat, and the transactivation responseelement (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. Ulich, C; Dunne, A; Parry, E; Hooker, CW; Gaynor, RB; Harrich, D
      Functional domains of tat required for efficient human immunodeficiency virus type 1 reverse transcription

      JOURNAL OF VIROLOGY
    19. Clever, JL; Eckstein, DA; Parslow, TG
      Genetic dissociation of the encapsidation and reverse transcription functions in the 5 ' R region of human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    20. Bruce, CB; Akrigg, A; Sharpe, SA; Hanke, T; Wilkinson, GWG; Cranage, MP
      Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice

      JOURNAL OF GENERAL VIROLOGY
    21. Huq, I; Ping, YH; Tamilarasu, N; Rana, TM
      Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides

      BIOCHEMISTRY
    22. Watson, K; Gooderham, NJ; Davies, DS; Edwards, RJ
      Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides

      BIOCHEMICAL PHARMACOLOGY
    23. Kameoka, M; Tanaka, Y; Ota, K; Itaya, A; Yamamoto, K; Yoshihara, K
      HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    24. JEANG KT
      TAT, TAT-ASSOCIATED KINASE, AND TRANSCRIPTION

      Journal of biomedical science
    25. CORALLINI A; BETTI M; RUSNATI M; CAMPIONI D; CIOMEI M; SOLA F; CALZA N; ZAULI G; PRESTA M; BARBANTIBRODANO G; CAPUTO A
      CHARACTERIZATION OF THE EFFECTS OF 2 POLYSULFONATED DISTAMYCIN-A DERIVATIVES, PNU145156E AND PNU153429, ON HIV TYPE-1 TAT PROTEIN

      AIDS research and human retroviruses
    26. Seewald, MJ; Metzger, AU; Willbold, D; Rosch, P; Sticht, H
      Structural model of the HIV-1 Tat(46-58)-TAR complex

      JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
    27. KOSEKI S; OHKAWA J; YAMAMOTO R; TAKEBE Y; TAIRA K
      A SIMPLE ASSAY SYSTEM FOR EXAMINATION OF THE INHIBITORY POTENTIAL IN-VIVO OF DECOY RNAS, RIBOZYMES AND OTHER DRUGS BY MEASURING THE TAT-MEDIATED TRANSCRIPTION OF A FUSION GENE COMPOSED OF THE LONG TERMINAL REPEAT OF HIV-1 AND A GENE FOR LUCIFERASE

      Journal of controlled release
    28. Faure, E
      X-rays-induced secretion of cellular factor(s) that enhance(s) HIV-1 promoter transcription in various non-irradiated transfected cell lines

      CELLULAR AND MOLECULAR BIOLOGY
    29. GOLD MO; YANG XZ; HERRMANN CH; RICE AP
      PITALRE, THE CATALYTIC SUBUNIT OF TAK, IS REQUIRED FOR HUMAN-IMMUNODEFICIENCY-VIRUS TAT TRANSACTIVATION IN-VIVO

      Journal of virology
    30. NARYSHKIN NA; GAIT MJ; IVANOVSKAYA MG
      RNA RECOGNITION AND REGULATION OF HIV-1 GENE-EXPRESSION BY VIRAL FACTOR TAT

      Biochemistry
    31. XIAO H; NEUVEUT C; BENKIRANE M; JEANG KT
      INTERACTION OF THE 2ND CODING EXON OF TAT WITH HUMAN EF-1-DELTA DELINEATES A MECHANISM FOR HIV-1-MEDIATED SHUTOFF OF HOST MESSENGER-RNA TRANSLATION

      Biochemical and biophysical research communications
    32. OPALENIK SR; DING Q; MALLERY SR; THOMPSON JA
      GLUTATHIONE DEPLETION ASSOCIATED WITH THE HIV-1 TAT PROTEIN MEDIATES THE EXTRACELLULAR APPEARANCE OF ACIDIC FIBROBLAST GROWTH-FACTOR

      Archives of biochemistry and biophysics
    33. HUQ I; WANG XL; RANA TM
      SPECIFIC RECOGNITION OF HIV-1 TAR RNA BY A D-TAT PEPTIDE

      Nature structural biology
    34. ZAPP ML; YOUNG DW; KUMAR A; SINGH R; BOYKIN DW; WILSON WD; GREEN MR
      MODULATION OF THE REV-RRE INTERACTION BY AROMATIC HETEROCYCLIC-COMPOUNDS

      Bioorganic & medicinal chemistry
    35. ELSOLH A; KUMAR NM; NAIR MPN; SCHWARTZ SA; LWEBUGAMUKASA JS
      AN RGD CONTAINING PEPTIDE FROM HIV-1 TAT-(65-80) MODULATES PROTOONCOGENE EXPRESSION IN HUMAN BRONCHOALVEOLAR CARCINOMA CELL-LINE, A549

      Immunological investigations
    36. YAMAMOTO R; KOSEKI S; OHKAWA J; MURAKAMI K; NISHIKAWA S; TAIRA K; KUMAR PKR
      INHIBITION OF TRANSCRIPTION BY THE TAR RNA OF HIV-1 IN A NUCLEAR EXTRACT OF HELA-CELLS

      Nucleic acids research
    37. CHANG HC; SAMANIEGO F; NAIR BC; BUONAGURO L; ENSOLI B
      HIV-1 TAT PROTEIN EXITS FROM CELLS VIA A LEADERLESS SECRETORY PATHWAYAND BINDS TO EXTRACELLULAR MATRIX-ASSOCIATED HEPARAN-SULFATE PROTEOGLYCANS THROUGH ITS BASIC REGION

      AIDS
    38. HARRICH D; ULICH C; GARCIAMARTINEZ LF; GAYNOR RB
      TAT IS REQUIRED FOR EFFICIENT HIV-1 REVERSE TRANSCRIPTION

      EMBO journal
    39. YANG LP; MORRIS GF; WANG ZD; MORRIS CB
      REPRESSION OF TUMOR NECROSIS FACTOR-BETA EXPRESSION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN IN CENTRAL NERVOUS SYSTEM-DERIVED GLIAL-CELLS

      Virus research
    40. FONG SE; SMANIK P; THAIS T; SMITH MC; JASKUNAS SR
      DETECTION OF SPECIFIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT-TAR COMPLEXES IN THE PRESENCE OF MILD DENATURING CONDITIONS

      Journal of virological methods
    41. FONG SE; SMANIK P; SMITH MC; JASKUNAS SR
      CATIONIC LIPOSOME-MEDIATED UPTAKE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN INTO CELLS

      Journal of virological methods
    42. RUEDIGER R; BREWIS N; OHST K; WALTER G
      INCREASING THE RATIO OF PP2A CORE ENZYME TO HOLOENZYME INHIBITS TAT-STIMULATED HIV-1 TRANSCRIPTION AND VIRUS PRODUCTION

      Virology
    43. FONG SE; GREENWOOD JD; WILLIAMSON JC; DERSE D; PALLANSCH LA; COPELAND T; RASMUSSEN L; MENTZER A; NAGASHIMA K; TOBIN G; GONDA MA
      BOVINE IMMUNODEFICIENCY VIRUS TAT GENE - CLONING OF 2 DISTINCT CDNAS AND IDENTIFICATION, CHARACTERIZATION, AND IMMUNOLOCALIZATION OF THE TAT GENE-PRODUCTS

      Virology
    44. FAVARO JP; ARRIGO SJ
      CHARACTERIZATION OF REV FUNCTION USING SUBGENOMIC AND GENOMIC CONSTRUCTS IN T-CELL AND COS-CELL

      Virology
    45. ROSENZWEIG M; MARKS DF; HEMPEL D; LISZIEWICZ J; JOHNSON RP
      TRANSDUCTION OF CD34(-CELL AND MACROPHAGE PROGENY FROM AIDS VIRUS-INFECTION() HEMATOPOIETIC PROGENITOR CELLS WITH AN ANTITAT GENE PROTECTS T)

      Journal of virology
    46. LENZ C; SCHEID A; SCHAAL H
      EXON-1 LEADER SEQUENCES DOWNSTREAM OF U5 ARE IMPORTANT FOR EFFICIENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENE-EXPRESSION

      Journal of virology
    47. COTTREZ F; MANCA F; DALGLEISH AG; ARENZANASEISDEDOS F; CAPRON A; GROUX H
      PRIMING OF HUMAN CD4(-SPECIFIC T-CELLS TO UNDERGO APOPTOSIS BY HIV-INFECTED MONOCYTES - A 2-STEP MECHANISM INVOLVING THE GP120 MOLECULE() ANTIGEN)

      The Journal of clinical investigation
    48. AMBROSINO C; RUOCCO MR; CHEN XN; MALLARDO M; BAUDI F; TREMATERRA S; QUINTO I; VENUTA S; SCALA G
      HIV-1 TAT INDUCES THE EXPRESSION OF THE INTERLEUKIN-6 (IL6) GENE BY BINDING TO THE IL6 LEADER RNA AND BY INTERACTING WITH CAAT ENHANCER-BINDING PROTEIN-BETA (NF-IL6) TRANSCRIPTION FACTORS

      The Journal of biological chemistry
    49. RUSNATI M; COLTRINI D; ORESTE P; ZOPPETTI G; ALBINI A; NOONAN D; DIFAGAGNA FD; GIACCA M; PRESTA M
      INTERACTION OF HIV-1 TAT PROTEIN WITH HEPARIN - ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE

      The Journal of biological chemistry
    50. METZGER AU; BAYER P; WILLBOLD D; HOFFMANN S; FRANK RW; GOODY RS; ROSCH P
      THE INTERACTION OF HIV-1 TAT(32-72) WITH ITS TARGET RNA - A FLUORESCENCE AND NUCLEAR-MAGNETIC-RESONANCE STUDY

      Biochemical and biophysical research communications
    51. TANAKA T; NAKAMURA T; TAKAGI H; SATO M
      MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL TBP-1 INTERACTING PROTEIN (TBPIP) - ENHANCEMENT OF TBP-1 ACTION ON TAT BY TBPIP

      Biochemical and biophysical research communications
    52. KIM JH; MCLINDEN RJ; MOSCA JD; VAHEY MT; GREENE WC; REDFIELD RR
      INHIBITION OF HIV REPLICATION BY SENSE AND ANTISENSE REV RESPONSE ELEMENTS IN HIV-BASED RETROVIRAL VECTORS

      Journal of acquired immune deficiency syndromes and human retrovirology
    53. MIYAZAKI Y; NOSAKA T; HATANAKA M
      THE POSTTRANSCRIPTIONAL REGULATOR REV OF HIV - IMPLICATIONS FOR ITS INTERACTION WITH THE NUCLEOLAR PROTEIN B23

      Biochimie
    54. PENG HR; CALLISON D; LI P; BURRELL C
      LONG-TERM PROTECTION AGAINST HIV-1 INFECTION CONFERRED BY TAT OR REV ANTISENSE RNA WAS AFFECTED BY THE DESIGN OF THE RETROVIRAL VECTOR

      Virology
    55. ARYA SK; GALLO RC
      HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 2-MEDIATED INHIBITION OF HIV TYPE-1 - A NEW APPROACH TO GENE-THERAPY OF HIV-INFECTION

      Proceedings of the National Academy of Sciences of the United Statesof America
    56. YANG XZ; HERRMANN CH; RICE AP
      THE HUMAN-IMMUNODEFICIENCY-VIRUS TAT PROTEINS SPECIFICALLY ASSOCIATE WITH TAK IN-VIVO AND REQUIRE THE CARBOXY-TERMINAL DOMAIN OF RNA-POLYMERASE-II FOR FUNCTION

      Journal of virology
    57. ULICH C; HARRICH D; ESTES P; GAYNOR RB
      INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IS ENHANCED BY A COMBINATION OF TRANSDOMINANT TAT AND REV PROTEINS

      Journal of virology
    58. CONANT K; MA MH; NATH A; MAJOR EO
      EXTRACELLULAR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN IS ASSOCIATED WITH AN INCREASE IN BOTH NF-KAPPA-B BINDING AND PROTEIN-KINASE-C ACTIVITY IN PRIMARY HUMAN ASTROCYTES

      Journal of virology
    59. SCHAFER SL; VLACH J; PITHA PM
      COOPERATION BETWEEN HERPES-SIMPLEX VIRUS TYPE 1-ENCODED ICPO AND TAT TO SUPPORT TRANSCRIPTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN-VIVO CAN OCCUR IN THE ABSENCE OF THE TAR BINDING-SITE

      Journal of virology
    60. WANG ZY; WANG XL; RANA TM
      PROTEIN ORIENTATION IN THE TAT-TAR COMPLEX DETERMINED BY PSORALEN PHOTOCROSS-LINKING

      The Journal of biological chemistry
    61. WANG ZY; RANA TM
      RNA CONFORMATION IN THE TAT-TAR COMPLEX DETERMINED BY SITE-SPECIFIC PHOTO-CROSS-LINKING

      Biochemistry
    62. JIANG MC; LIN JK; CHEN SSL
      INHIBITION OF HIV-1 TAT-MEDIATED TRANSACTIVATION BY QUINACRINE AND CHLOROQUINE

      Biochemical and biophysical research communications
    63. HOLMES AM
      IN-VITRO PHOSPHORYLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN BY PROTEIN-KINASE-C - EVIDENCE FOR THE PHOSPHORYLATION OF AMINO-ACID RESIDUE SERINE-46

      Archives of biochemistry and biophysics
    64. ENSOLI B; GALLO RC
      AIDS-ASSOCIATED KAPOSIS-SARCOMA - A NEW PERSPECTIVE OF ITS PATHOGENESIS AND TREATMENT

      Proceedings of the Association of American Physicians
    65. LI QG; ZHANG YJ; LIANG Y; FENG CQ; LI YZ; SJOBERG R; JIANG Y; WANG NF; WADELL G
      THE MORPHOGENESIS OF A CHINESE STRAIN OF HIV-1 FORMING INCLUSION-BODIES IN JURKAT-TAT-III CELLS

      Journal of acquired immune deficiency syndromes and human retrovirology
    66. POWELL DM; ZHANG MJ; KONINGS DAM; WINGFIELD PT; STAHL SJ; DAYTON ET; DAYTON AI
      SEQUENCE SPECIFICITY IN THE HIGHER-ORDER INTERACTION OF THE REV PROTEIN OF HIV-1 WITH ITS TARGET SEQUENCE, THE RRE

      Journal of acquired immune deficiency syndromes and human retrovirology
    67. TUNG CH; WANG JH; LEIBOWITZ MJ; STEIN S
      DUAL-SPECIFICITY INTERACTION OF HIV-1 TAR RNA WITH TAT PEPTIDE-OLIGONUCLEOTIDE CONJUGATES

      Bioconjugate chemistry
    68. LEE AH; SUH YA; SUNG YC
      TAT AND NEF DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATES EFFICIENTLY IN TAT-EXPRESSING T-CELLS

      Molecules and cells
    69. TAYLOR JP; POMERANTZ RJ; OAKES JW; KHALILI K; AMINI S
      A CNS-ENRICHED FACTOR THAT BINDS TO NF-KAPPA-B AND IS REQUIRED FOR INTERACTION WITH HIV-1 TAT

      Oncogene
    70. REDDY TR; SUHASINI M; RAPPAPORT J; LOONEY DJ; KRAUS G; WONGSTAAL F
      MOLECULAR-CLONING AND CHARACTERIZATION OF A TAR-BINDING NUCLEAR FACTOR FROM T-CELLS

      AIDS research and human retroviruses
    71. KIRA T; MERIN JP; BABA M; SHIGETA S; OKAMOTO T
      ANTI-TAT MTT ASSAY - A NOVEL ANTI-HIV DRUG SCREENING SYSTEM USING THEVIRAL REGULATORY NETWORK OF REPLICATION

      AIDS research and human retroviruses
    72. PURI RK; LELAND P; AGGARWAL BB
      CONSTITUTIVE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT GENE INHIBITS INTERLEUKIN-2 AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN A HUMAN CD4(-LYMPHOID (H9) CELL-LINE() T)

      AIDS research and human retroviruses
    73. CHANG LJ; ZHANG CS
      INFECTION AND REPLICATION OF TAT(-) HUMAN IMMUNODEFICIENCY VIRUSES - GENETIC ANALYSES OF LTR AND TAT MUTATIONS IN PRIMARY AND LONG-TERM HUMAN LYMPHOID-CELLS

      Virology
    74. HARMACHE A; VITU C; RUSSO P; BOUYAC M; HIEBLOT C; PEVERI P; VIGNE R; SUZAN M
      THE CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS TAT GENE IS DISPENSABLE FOR EFFICIENT VIRAL REPLICATION IN-VITRO AND IN-VIVO

      Journal of virology
    75. DESAIYAJNIK V; HADZIC E; MODLINGER P; MALHOTRA S; GECHLIK G; SAMUELS HH
      INTERACTIONS OF THYROID-HORMONE RECEPTOR WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) LONG TERMINAL REPEAT AND THE HIV-1 TAT TRANSACTIVATOR

      Journal of virology
    76. CUPELLI LA; HSU MC
      THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT ANTAGONIST, RO-5-3335, PREDOMINANTLY INHIBITS TRANSCRIPTION INITIATION FROM THE VIRAL PROMOTER

      Journal of virology
    77. LISZIEWICZ J; SUN D; TRAPNELL B; THOMSON M; CHANG HK; ENSOLI B; PENG B
      AN AUTOREGULATED DUAL-FUNCTION ANTITAT GENE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENE-THERAPY

      Journal of virology
    78. HAUBRICH RH; FLEXNER C; LEDERMAN MM; HIRSCH M; PETTINELLI CP; GINSBERG R; LIETMAN P; HAMZEH FM; SPECTOR SA; RICHMAN DD; HAMMER S; COOLEY T; GULICK R; SULLIVAN M; SPINA C; FRASER A; LATHEY J; BASSIAKOS Y; CHANCE M; DROBNES C; CORUELL E; GRUE L; RAINES C; KUWAHARA S; MCPHERSON J
      A RANDOMIZED TRIAL OF THE ACTIVITY AND SAFETY OF RO-24-7429 (TAT ANTAGONIST) VERSUS NUCLEOSIDE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      The Journal of infectious diseases
    79. LUZNIK L; KRAUS G; GUATELLI J; RICHMAN D; WONGSTAAL F
      TAT-INDEPENDENT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUSES

      The Journal of clinical investigation
    80. MIYAZAKI Y; TAKAMATSU T; NOSAKA T; FUJITA S; MARTIN TE; HATANAKA M
      THE CYTOTOXICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV - IMPLICATIONS FOR ITS INTERACTION WITH THE NUCLEOLAR PROTEIN B23

      Experimental cell research
    81. LONG KS; CROTHERS DM
      INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT-DERIVED PEPTIDES WITH TAR RNA

      Biochemistry
    82. CHANG HK; GENDELMAN R; LISZIEWICZ J; GALLO RC; ENSOLI B
      BLOCK OF HIV-1 INFECTION BY A COMBINATION OF ANTISENSE TAT RNA AND TAR DECOYS - A STRATEGY FOR CONTROL OF HIV-1

      Gene therapy
    83. LIU JS; WOFFENDIN C; YANG ZY; NABEL GJ
      REGULATED EXPRESSION OF A DOMINANT-NEGATIVE FORM OF REV IMPROVES RESISTANCE TO HIV REPLICATION IN T-CELLS

      Gene therapy
    84. COFFEN DL; HUANG TN; RAMER SE; WEST RC; CONNELL EV; SCHUTT AD; HSU MC
      DISCOVERY OF A DRUG LEAD EMPLOYING A PEPTIDE LIBRARY - INHIBITION OF HIV-1 TAT AND VIRAL REPLICATION BY THE TRIPEPTIDE YPG-NH2

      Antiviral chemistry & chemotherapy
    85. STEINAA L; SORENSEN AM; NIELSEN JO; HANSEN JES
      ANTIBODY TO HIV-1 TAT PROTEIN INHIBITS THE REPLICATION OF VIRUS IN CULTURE

      Archives of virology
    86. JOHNSON R; KANEENE JB; LLOYD JW
      LYMPHOCYTE COLONY FORMATION BY ALEUKEMIC SHEEP INFECTED WITH BOVINE LEUKEMIA-VIRUS

      Comparative immunology, microbiology and infectious diseases
    87. ZEICHNER SL
      THE MOLECULAR-BIOLOGY OF HIV - INSIGHTS INTO PATHOGENESIS AND TARGETSFOR THERAPY

      Clinics in perinatology
    88. RAPPAPORT J; KOPP JB; KLOTMAN PE
      HOST VIRUS INTERACTIONS AND THE MOLECULAR REGULATION OF HIV-1 - ROLE IN THE PATHOGENESIS OF HIV-ASSOCIATED NEPHROPATHY

      Kidney international
    89. SCHOBORG RV; SALTARELLI MJ; CLEMENTS JE
      A REV PROTEIN IS EXPRESSED IN CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS (CAEV)-INFECTED CELLS AND IS REQUIRED FOR EFFICIENT VIRAL REPLICATION

      Virology
    90. RIGGS NL; LITTLE SJ; RICHMAN DD; GUATELLI JC
      BIOLOGICAL IMPORTANCE AND COOPERATIVITY OF HIV-1 REGULATORY GENE SPLICE ACCEPTERS

      Virology
    91. SALTARELLI MJ; SCHOBORG R; PAVLAKIS GN; CLEMENTS JE
      IDENTIFICATION OF THE CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS REV PROTEIN AND ITS CIS-ACTING REV-RESPONSIVE ELEMENT

      Virology
    92. SMYTHE JA; SUN D; THOMSON M; MARKHAM PD; REITZ MS; GALLO RC; LISZIEWICZ J
      A REV-INDUCIBLE MUTANT GAG GENE STABLY TRANSFERRED INTO T-LYMPHOCYTES- AN APPROACH TO GENE-THERAPY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      Proceedings of the National Academy of Sciences of the United Statesof America
    93. CHANG KY; TINOCO I
      CHARACTERIZATION OF A KISSING HAIRPIN COMPLEX DERIVED FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS GENOME

      Proceedings of the National Academy of Sciences of the United Statesof America
    94. KLAVER B; BERKHOUT B
      COMPARISON OF 5' AND 3' LONG TERMINAL REPEAT PROMOTER FUNCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS

      Journal of virology
    95. TAYLOR JP; POMERANTZ RJ; RAJ GV; KASHANCHI F; BRADY JN; AMINI S; KHALILI K
      CENTRAL NERVOUS SYSTEM-DERIVED CELLS EXPRESS A KAPPA-B-BINDING ACTIVITY THAT ENHANCES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSCRIPTION IN-VITRO AND FACILITATES TAR-INDEPENDENT TRANSACTIVATION BY TAT

      Journal of virology
    96. STAFFA A; COCHRANE A
      THE TAT REV INTRON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS INEFFICIENTLY SPLICED BECAUSE OF SUBOPTIMAL SIGNALS IN THE 3' SPLICE-SITE/

      Journal of virology
    97. BUONAGURO L; BUONAGURO FM; GIRALDO G; ENSOLI B
      THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN TRANSACTIVATES TUMOR-NECROSIS-FACTOR BETA-GENE EXPRESSION THROUGH A TAR-LIKE STRUCTURE

      Journal of virology
    98. POPIK W; PITHA PM
      THE PRESENCE OF TAT PROTEIN OR TUMOR-NECROSIS-FACTOR-ALPHA IS CRITICAL FOR HERPES-SIMPLEX VIRUS TYPE 1-INDUCED EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology
    99. HAMMARSKJOLD ML; LI HB; REKOSH D; PRASAD S
      HUMAN-IMMUNODEFICIENCY-VIRUS ENV EXPRESSION BECOMES REV-INDEPENDENT IF THE ENV REGION IS NOT DEFINED AS AN INTRON

      Journal of virology
    100. OTAKE K; FUJII Y; NAKAYA T; NISHINO Y; ZHONG Q; FUJINAGA K; KAMEOKA M; OHKI K; IKUTA K
      THE CARBOXYL-TERMINAL REGION OF HIV-1 NEF PROTEIN IS A CELL-SURFACE DOMAIN THAT CAN INTERACT WITH CD4(-CELLS() T)

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 19:00:55